SenesTech, Inc. (SNES)

Market Cap	9.53M +114.2%
Revenue (ttm)	2.23M +15.7%
Net Income	-6.78M
EPS	-1.59
Shares Out	5.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,345
Open	1.800
Previous Close	1.790
Day's Range	1.770 - 1.890
52-Week Range	1.410 - 6.240
Beta	0.19
Analysts	Strong Buy
Price Target	10.00 (+446.45%)
Earnings Date	May 12, 2026

About SNES

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the act...

• Industry: Specialty Chemicals
• Sector: Materials
• IPO Date: Dec 8, 2016
• Employees: 24
• Stock Exchange: NASDAQ
• Ticker Symbol: SNES
• Website: https://www.senestech.com

Financial Performance

In 2025, SenesTech's revenue was $2.22 million, an increase of 19.60% compared to the previous year's $1.86 million. Losses were -$6.38 million, 3.22% more than in 2024.

Analyst Summary

According to one analyst, the rating for SNES stock is "Strong Buy" and the 12-month stock price target is $10.0.

Price Target

$10.0

(446.45% upside)

Analyst Consensus: Strong Buy